Inspire Medical Accelerates $75M Stock Repurchase as Part of $150M Buyback Plan
Inspire Medical Accelerates $75M Stock Repurchase as Part of $150M Buyback Plan
Inspire Medical Systems, Inc. (NYSE:INSP) ("Inspire," or the "Company"), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today announced that it entered into an accelerated share repurchase ("ASR") transaction under an agreement with Goldman Sachs & Co. LLC, to repurchase an aggregate of $75.0 million of shares of the Company's common stock, par value $0.001 per share. The ASR transaction is being completed pursuant to a previously announced $150.0 million share repurchase program authorized by the Company's Board of Directors.
Inspire医疗系统公司（纽交所：INSP）（"Inspire"或"公司"），一家专注于开发和推广创新的、微创解决方案，用于阻塞性睡眠呼吸暂停患者的医疗科技公司，今天宣布与高盛的高盛公司达成协议，进行了一项加速股份回购（ASR）交易，以回购公司普通股股票总额为7500万美元，每股面值为0.001美元。 ASR交易根据公司董事会授权的15000万美元股份回购计划完成。
